Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DTC - Differentiated Thyroid Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT07485569
What this trial is testing

Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial

Who this might be right for
Thyroid Cancer Stage IVAnaplastic Thyroid CancerDifferentiated Thyroid Cancer+1 more
Radboud University Medical Center 10
Not applicableUnknownNCT01641679
What this trial is testing

PET Evaluation of Recurrent Differentiated Thyroid Cancer

Who this might be right for
Thyroid NeoplasmsDifferentiated Thyroid Cancer
The Netherlands Cancer Institute 100
Not applicableActive Not RecruitingNCT01704586
What this trial is testing

I-124 PET/CT Based Remnant Radioiodine Ablation Decision Concept in Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Carcinoma
University of Wuerzburg 340
Testing effectiveness (Phase 2)Looking for participantsNCT06458036
What this trial is testing

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

Who this might be right for
Differentiated Thyroid CancerPediatric CancerCancer+1 more
Children's Hospital of Philadelphia 13
Testing effectiveness (Phase 2)Looking for participantsNCT05783323
What this trial is testing

Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid CancerPediatric CancerCancer+1 more
Children's Hospital of Philadelphia 13
Testing effectiveness (Phase 2)Ended earlyNCT03506048
What this trial is testing

Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Gland CarcinomaThyroid Gland Follicular CarcinomaThyroid Gland Papillary Carcinoma
Emory University 4
Large-scale testing (Phase 3)Study completedNCT00794053
What this trial is testing

The Usefulness of Staining Lymph Nodes During Operations for Cancer Thyroid in Detecting the Nodes That Have Cancer

Who this might be right for
Thyroid CancerLymph Node Metastasis
University of Alexandria 45
Not applicableLooking for participantsNCT07068542
What this trial is testing

Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer

Who this might be right for
Advanced Thyroid CarcinomaRadioiodine-refractory Differentiated Thyroid CancerPoorly Differentiated Thyroid Carcinoma
Zhejiang Provincial People's Hospital 94
Not applicableLooking for participantsNCT05575440
What this trial is testing

Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Gland CarcinomaThyroid Gland Follicular CarcinomaThyroid Gland Papillary Carcinoma
Mayo Clinic 24
Testing effectiveness (Phase 2)Study completedNCT01788982
What this trial is testing

Nintedanib(BIBF1120) in Thyroid Cancer

Who this might be right for
Medullary Thyroid Cancer (MTC)Differentiated Thyroid Cancer (DTC)
European Organisation for Research and Treatment of Cancer - EORTC 100
Post-approval studies (Phase 4)Ended earlyNCT03065218
What this trial is testing

99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients

Who this might be right for
Thyroid Cancer
Medstar Health Research Institute 4
Very early researchStudy completedNCT00718770
What this trial is testing

A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression

Who this might be right for
Thyroid Cancer
University of Colorado, Denver 10
Large-scale testing (Phase 3)UnknownNCT03048877
What this trial is testing

Efficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Cancer
Peking Union Medical College Hospital 118
Early research (Phase 1)Looking for participantsNCT07287748
What this trial is testing

A Phase I Trial of Af-001 in Patients With Differentiated Thyroid Cancer

Who this might be right for
DTC - Differentiated Thyroid Cancer
Alpha Fusion Inc. 38
Not applicableStudy completedNCT05078853
What this trial is testing

Thyroglobulin Point of Care Assay for Rapid Detection of Metastatic Differentiated Thyroid Carcinoma

Who this might be right for
Differentiated Thyroid CancerLymph Node Metastases
Soroka University Medical Center 250
Not applicableActive Not RecruitingNCT04948437
What this trial is testing

Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer

Who this might be right for
Thyroid CancerPapillary Thyroid CancerFollicular Thyroid Cancer
National Taiwan University Hospital 103
Not applicableActive Not RecruitingNCT03794375
What this trial is testing

Primary Care Transfer for Thyroid Cancer Patients

Who this might be right for
Differentiated Thyroid Cancer
Hospital de Clinicas de Porto Alegre 206
Not applicableActive Not RecruitingNCT03416686
What this trial is testing

Radiofrequency in Differentiated Thyroid Cancer Metastatic Lymph Node: Prospective Study of Safety and Efficacy

Who this might be right for
Differentiated Thyroid Cancer
Assistance Publique - Hôpitaux de Paris 14
Testing effectiveness (Phase 2)Study completedNCT02390934
What this trial is testing

Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid Cancer

Who this might be right for
Thyroid Cancer
Gustave Roussy, Cancer Campus, Grand Paris 13
Post-approval studies (Phase 4)Study completedNCT03573960
What this trial is testing

Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer

Who this might be right for
Thyroid Neoplasms
Eisai Pharmaceuticals India Pvt. Ltd 50
Next Page